AWA
CTOR

Arkadios Wealth Advisors’s Citius Oncology CTOR Stock Holding History

Arkadios Wealth Advisors’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.23K Hold
11,666
– – ﹤0.01% 1688
2025
Q4 		$11.7K Hold
11,666
– – ﹤0.01% 1558
2025
Q3 		$23.7K Hold
11,666
– – ﹤0.01% 1455
2025
Q2 		$50.7K Buy
+11,666
New +$13.6K ﹤0.01% 1285

Other funds holding CTOR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Arkadios Wealth Advisors's CTOR Position: Q1 2026 in Review

Arkadios Wealth Advisors held its Citius Oncology (CTOR) position steady in Q1 2026 at 11,666 shares worth $7.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Arkadios Wealth Advisors first reported a position in CTOR in Q2 2025 and has held it in 4 quarters since. The position peaked at $50.7K in Q2 2025. 14 funds tracked by Wall St. Rank hold CTOR as of Q1 2026.

  • Arkadios Wealth Advisors held 11,666 shares of Citius Oncology worth $7.23K as of Q1 2026.
  • Arkadios Wealth Advisors left its Citius Oncology share count unchanged in Q1 2026.
  • Citius Oncology made up ﹤0.01% of Arkadios Wealth Advisors's portfolio in Q1 2026, its #1688 holding.
  • Arkadios Wealth Advisors first reported a position in Citius Oncology in Q2 2025 and has held it in 4 quarters since.
  • Arkadios Wealth Advisors's Citius Oncology position peaked at $50.7K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Citius Oncology as of Q1 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.